HomepageBlogMitsui Chemicals to Re-Enter Nucleic Acid Drug CDMO Market Blog Market Mitsui Chemicals to Re-Enter Nucleic Acid Drug CDMO Market admin Posted on August 14, 2023 Mitsui Chemicals Inc. (TYO:4183) plans to get back involved in the CDMO business for nucleic acid drugs. By 2025, the…… Please subscribe to read the full story. LEAVE A RESPONSE Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Post navigation Next PostChemical Innovation: Unveiling the Dynamics of Japan’s Thriving Chemical Industry You Might Also Like Blog Mitsubishi Pencil to Launch CNT Dispersant for LiBs by 2023 admin August 14, 2023 Blog Mitsubishi Chemical Holdings Considers Increased Output of Purified Sulfuric Acid in Taiwan admin August 14, 2023 Blog Biotech is Key to Future Drug Development, Says Chugai Pharmaceutical CEO admin August 14, 2023 Blog Philips to Build IoT-Based Health Care Network in Japan admin August 14, 2023
Blog Mitsubishi Chemical Holdings Considers Increased Output of Purified Sulfuric Acid in Taiwan admin August 14, 2023
Blog From Chemistry to Energy: Unveiling the Integral Role of Chemical Reactions in Power Generation admin September 30, 2023